We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Breakthrough Implant Marks Paradigm Shift in Treatment of Gastroesophageal Reflux

By HospiMedica International staff writers
Posted on 31 May 2023

Acid reflux, a condition characterized by the regurgitation of the stomach's acid content into the esophagus, affects approximately 400 million individuals daily, making it the second-largest treatment field globally. More...

This condition can progress into a chronic disease known as gastroesophageal reflux disease (GERD) when acid reflux episodes become frequent. Traditional surgical treatments have been associated with numerous complications, such as difficulties in swallowing and an inability to belch or vomit. This is largely due to these methods encircling the food passage to bolster the closing ring muscle. Now, a novel implant based on a unique invention offers a solution to acid reflux without interfering with the food passageway.

Implantica AG’s (Zug, Switzerland) RefluxStop is a CE-marked implant designed to prevent gastroesophageal reflux and could potentially revolutionize the treatment of acid reflux. Unlike drug therapy, RefluxStop not only manages acid reflux symptoms but also eliminates stomach fluid regurgitation. This innovative, non-active implant is positioned on the upper section of the stomach through laparoscopic (keyhole) surgery.

The RefluxStop device obstructs the reflux process, which is triggered by anatomical misalignment associated with abnormal fundus contractions that also involve fluid, along with sphincter relaxation. Furthermore, it acts as a mechanical barrier that prevents the lower esophageal sphincter (LES) from shifting into the thorax. With abdominal pressure, the LES can function normally. RefluxStop was granted CE mark approval based on a multi-center clinical study demonstrating the device's safety and efficacy in patients. The study suggests that RefluxStop leads to lower complication rates compared to existing surgical treatments. Recently, RefluxStop won the Medtop Tech Award for the most innovative medical device among all competitors.

"We thank Medtop for acknowledging Implantica's premier commercial product, RefluxStop, as the most innovative medical device for 2023," said Dr. Peter Forsell, CEO and founder of Implantica. "This is validation that RefluxStop truly is a breakthrough in treating acid reflux. RefluxStop is making strides in demonstrating outstanding clinical results, enabling Reflux experts to offer a unique therapeutic solution to help millions of patients with acid reflux around the world."

Related Links:
Implantica AG


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Immobilization System
Cranial 4Pi Immobilization
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Brain-Computer Interface Enables Responses in Some Unresponsive ICU Patients

Cognitive motor dissociation occurs when patients retain signs of consciousness but cannot move or speak to communicate. In the ICU, this hidden consciousness can be difficult to distinguish from coma... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.